High-risk prescribing in an Irish primary care population: trends and variation

Catherine J Byrne1, Caitriona Cahir1, Carmel Curran2

  • 1Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

Insights

High-risk prescribing (HRP) in Ireland decreased from 2011-2015, but still affects many patients. Variations between general practitioners and pharmacies highlight opportunities to improve medication safety for older adults.

Area of Science:

  • Health Sciences
  • Pharmaceutical Sciences
  • Gerontology

Background:

  • High-risk prescribing (HRP) poses a significant threat to patient safety, particularly in community-dwelling older adults.
  • Understanding the prevalence and contributing factors of HRP is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the prevalence of HRP in Ireland between 2011 and 2015 using validated indicators.
  • To identify factors associated with HRP and analyze variations in HRP rates among general practitioners (GPs) and in prescription dispensing by pharmacies.

Main Methods:

  • A repeated cross-sectional study utilizing a national pharmacy claims database.
  • Consensus-validated prescribing indicators were applied to pharmacy claims data.
  • Multilevel logistic regression models were employed to analyze factors associated with HRP and dispensing patterns.

Main Results:

  • Significant reductions in HRP rates were observed from 2011 (21.9%) to 2015 (15.1%).
  • Key HRP indicators in 2015 included NSAID use without gastroprotection in the elderly, concurrent warfarin and antiplatelet/antibiotic use, and high-dose digoxin prescriptions.
  • HRP prevalence increased with age and the number of chronic medications. Significant variations in HRP rates were found between GPs and in dispensing practices between pharmacies, even after controlling for patient-level factors.

Conclusions:

  • While HRP in Ireland has declined, certain prescribing practices remain a concern.
  • The identified variations between GPs and pharmacies indicate potential for improving medication safety in community care, especially for vulnerable elderly populations.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
59
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
57
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
325
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
230
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K